显微照相皮肤病学手术(MDS)最近成为皮肤病学中的董事会认证领域,并于2021年10月进行了首次董事会检查。有资格,皮肤科医生必须通过研究生医学教育认证委员会(ACGME)完成研究金或证明Mohs显微外科手术的积极实践。积极实践的证明从2021年至2025年,之后,参加认证考试的人必须证明完成了ACGME认可的奖学金。这项研究旨在收集通过MDS委员会认证考试的医生的人口统计信息。比较了经过研究金培训的医生和未经研究金培训的医生以及Mohs组织的成员和非成员之间的MedicareMohs显微外科手术病例量。通过考试的医生姓名可在公开的美国皮肤病学委员会网站上访问。从2019年开始,使用Medicare数据库筛选Mohs手术病例数,并使用美国Mohs外科学会(ACMS)和美国Mohs外科学会(ASMS)医师查找工具来确定活跃会员资格。未在Medicare数据库中的医师和在过去三年内完成ACGME认可的研究金的医师被排除在病例量分析之外。1673名皮肤科医生通过了第一次认证考试。比较了这些医生中1310例的MedicareMohs病例量。与未接受ACMS/ACGME研究金培训的医生相比,Mohs手术病例的中位数(四分位数范围(IQR))明显高于未接受过ACMS/ACGME研究金培训的医生(370例(IQR:211-560)与138例(IQR:37-284),p<0.001)。与非成员相比,ACMS和/或ASMS成员的病例中位数也较高(334例(IQR:160-526)与95例(IQR:6-246),p<0.001)。鉴于在没有完成ACMS/ACGME认可的研究金的情况下参加MDS考试的5年窗口,更多未经正式培训的医生可能会选择获得董事会认证。此外,较少的皮肤科医生可能会选择完成ACMS/ACGME认可的研究金,因为它不是董事会认证所必需的。随着越来越多的皮肤科医生获得MDS认证,评估Mohs手术的积极实践并定义熟练程度指标可能变得重要。
Micrographic dermatologic surgery (MDS) recently became a board-certified field within dermatology with the first board examination administered in October 2021. To be eligible, dermatologists must have completed a fellowship through the Accreditation Council for Graduate Medical Education (ACGME) or attest to active practice of Mohs micrographic surgery. Attestation of active practice is available from 2021-2025, after which, those sitting for the certifying examination must demonstrate completion of an ACGME-accredited fellowship. This study aimed to compile demographic information on physicians who passed the MDS board certification examination. Medicare Mohs micrographic surgery
case volume was compared between fellowship-trained and non-fellowship-trained physicians as well as between members and non-members of Mohs organizations. Names of physicians who passed the examination were accessed on the publicly available American Board of Dermatology website. The Medicare database was used to screen for Mohs surgery
case numbers from 2019, and the American College of Mohs Surgery (ACMS) and American Society for Mohs Surgery (ASMS) physician finder tools were used to determine active membership. Physicians not in the Medicare database and those who completed an ACGME-accredited fellowship within the past three years were excluded from
case volume analysis. 1673 dermatologists passed the first certifying examination. Medicare Mohs
case volumes were compared for 1310 of these physicians. The median number (interquartile range (IQR)) of Mohs surgery cases was significantly higher for physicians who were ACMS/ACGME-fellowship-trained compared to those who were not (370 cases (IQR: 211-560) vs 138 cases (IQR: 37-284), p < 0.001). Members of ACMS and/or ASMS also performed a higher median number of cases compared to non-members (334 cases (IQR: 160-526) vs 95 cases (IQR: 6-246), p < 0.001). Given the 5-year window to take the MDS examination without having completed an ACMS/ACGME-accredited fellowship, more physicians without formal training may choose to become board certified. In addition, less dermatologists may choose to complete an ACMS/ACGME-accredited fellowship since it is not required for board certification. As more dermatologists become board certified in MDS, it may become important to assess for active practice of Mohs surgery and define proficiency metrics.